logo
15:43 Dec 05

Concord Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Biotechnology
Up
1408.40
+6.80 (+0.49%)
Sector Pharmaceuticals & Biotechnology Industry Biotechnology

Concord Biotech Ltd. Financials

Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Up
1408.40
+6.80 (+0.49%)
15:43 Dec 05
Quality
image/svg+xml

64/100
High Financial Strength

Valuation
image/svg+xml

26/100
Expensive Valuation

Technical

40/100
Technically Neutral

Strength

8

Weakness

7

Opportunity

0

Threats

1

20.50 %

ROE %

18.26 %

ROA %

30.97

EPS

173.27

BVPS

30.96 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
712.93 853.17 1016.94 1200.09 1125.15
Operating Expenses +
439.66 509.88 585.39 693.76 686.91
Raw Material
187.99 195.84 241.28 320.3 307.45
Increase Decrease in Cost
-23.98 -15.63 -12.08 -14.79 -32.42
Other Manufacturing Expense
0 0 0 0 55.78
Employee Cost
95.69 110.28 123.05 138.93 155.97
Miscellaneous Expenses
241.42 276.93 346.62 361.3 200.13
Operating Profit
273.27 343.29 431.55 506.33 438.24
Other Income
23.42 35.31 33.78 44.45 51.14
Depreciation
50.05 54.03 53.59 54.37 64.05
Interest
5.48 4.51 2.55 0.53 0.32
Profit before tax and exceptio..
241.16 320.05 409.19 495.88 425.01
Exceptional Items
0 0 0 0 0
PBT
241.16 320.05 409.19 495.88 425.01
Provision for Taxation
62.59 81.93 104.46 122.91 105.68
Net Profit
178.57 238.13 304.73 372.96 319.37
NET Profit after MI
174.93 240.09 308.1 371.64 323.95
EPS
16.72 22.95 29.45 35.52 30.92
Operating Profit Margin (%)
38.33 40.24 42.44 42.19 38.95
Net Profit Margin (%)
24.54 28.14 30.3 30.97 28.79

Concord Biotech Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 44.10 44.10 44.10 44.10 44.10 44.10
FII 8.00 9.10 9.40 8.30 8.10 7.10
Public 9.60 8.90 9.10 9.70 9.90 10.40
Others 38.30 37.90 37.40 37.90 37.90 38.40
Shareholder Shares Holding %
Research 360 logo
Download Our App On: